Previsioni

Non sono disponibili dati degli analisti per questa azienda.

Notizie Vai al feed delle notizie

SUGI PHARMACY to report quarterly results on April 9; analysts see significantly lower EPS, revenue rises

SUGI PHARMACY will release figures for the quarter ended February 28, 2026 on April 9, 2026. Three analysts expect an average EPS of 17.45 JPY (prior year: 36.65 JPY). Six analysts forecast revenue of 258.54 billion JPY, up 6.22% versus the same quarter last year. For the just-ended fiscal year, seven analysts' average estimates are EPS of 248.14 JPY (prior year: 141.96 JPY) and revenue of 1,008.86 billion JPY (prior year: 878.02 billion JPY). » Altro su finanzen.net
SUGI PHARMACY to release quarterly results on January 8, analysts see strong profit and revenue growth

SUGI PHARMACY will publish the quarter-end balance sheet for the period to November 30, 2025 on January 8. Three analysts expect EPS of JPY 41.86 per share (+26.31% vs. the prior year) and six analysts forecast revenue of JPY 247.85 billion (+12.25% vs. the prior year). For the current fiscal year, consensus estimates are JPY 246.97 earnings per share and annual revenue of JPY 1,009.77 billion. » Altro su finanzen.net
SUGI PHARMACY expects higher quarterly profit and revenue

SUGI PHARMACY is expected to announce results for the most recent quarter on 08.01.2026. Three analysts forecast an average EPS of 41.86 JPY versus 33.14 JPY a year earlier, with average revenue of 246.66 billion JPY versus 220.81 billion JPY. For the current fiscal year, the average estimates from ten analysts are earnings per share of 247.30 JPY (prior year 141.96 JPY) and revenue of 1,009.63 billion JPY (prior year 878.02 billion JPY). » Altro su finanzen.net

Dividendi storici Dividendi

Tutte le metriche sui dividendi Tutte le metriche

Nel 2025, Sugi ha già distribuito 0,20 € di dividendi. L'ultimo pagamento è avvenuto a novembre 2025.

Dati finanziari dell'azienda

Nell'ultimo trimestre, Sugi ha registrato ricavi pari a 1,46 Mld € e un utile netto di 37,17 Mln €

(EUR)	maggio 2026	YoY
Ricavi	1,46 Mld	3,07%
Utile lordo	448,88 Mln	2,94%
Utile netto	37,17 Mln	71,37%
EBITDA	94,71 Mln	1,23%

Dati fondamentali

Metrica	Valore
Capitalizzazione di mercato	2,78 Mld €
Numero di azioni	372,11 Mln
Massimo/minimo a 52 settimane	11,18 € - 7,18 €
Rendimento da dividendo	1,16%
Dividendi TTM	0,0847 €
Beta	0,28
Rapporto P/E	15,70
Rapporto PEG	-0,63
Rapporto P/B	1,64
Rapporto P/S	0,48

Profilo aziendale

Sugi Holdings Co.,Ltd. betreibt Drogerien in Japan. Darüber hinaus bietet das Unternehmen Krankenpflegedienste und häusliche Pflegedienstleistungen an. Zum 1. Juni 2019 betrieb das Unternehmen 1.190 Filialen. Sugi Holdings Co.,Ltd. wurde 1976 gegründet und hat seinen Hauptsitz in Obu, Japan.